Over the last 15 years MIT has played a central role in building a new field of study that aims to understand the myriad ways these microbes affect human health—and how we might harness their power to improve it.
CMIT Clinical Scientist Marjolein Klaassen, MD, PhD, was selected for the Inflammatory Bowel Diseases journal’s award for best basic science/translational article of 2024.